In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations ...

Healthcare professionals must stop supplying the affected batch, quarantine stock, and return it to suppliers.

Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian ...

The VISTA trial is evaluating and comparing 2 dose levels of laru-zova to an untreated control group for the treatment of ...

EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute, is advancing Rose Bengal Photodynamic ...

Alice T. Epitropoulos, MD, FACS, outlines her approach to managing evaporative dry eye. This includes diagnosing meibomian gland dysfunction, using thermal pulsation to clear gland blockages, and ...

Perfuse Therapeutics, Inc has shared positive results from 2 Phase 2 clinical trials of PER-001, targeting glaucoma and diabetic retinopathy. PER-001 is a first-in-class endothelin antagonist ...

We have a few rooms dedicated to diagnostic testing where patients undergo a thorough evaluation—every test that’s appropriate for whichever procedure is discussed. This also helps us take care of ...

Key Takeaways Instant coffee consumption is genetically linked to a 6.92-fold increased risk of dry AMD, suggesting high-risk individuals should avoid it. The study used genome-wide association ...